Complement-Targeted Therapies for CIDP: Building on the Learnings From PNS 2024

Complement-Targeted Therapies for CIDP: Building on the Learnings From PNS 2024

In this activity expert faculty analyze key new data from clinical trials in chronic inflammatory demyelinating polyneuropathy (CIDP) presented at the Peripheral Nerve Society (PNS) 2024 meeting.

  • Provider:Partners for Advancing Clinical Education (PACE)
  • Activity Link: https://nexusmedx.motivelms.com/browse/preview/292
  • Start Date: 2024-10-10 05:00:00
  • End Date: 2024-10-10 05:00:00
  • Credit Details: AMA PRA Category 1 Credit™️: 0.5 hours
  • Commercial Support: Source: Genzyme (Any division) - Amount: 75000.0 - Is Kind Support: False
  • Activity Type: Enduring Material
  • CME Finder Type: Online Learning
  • Fee to Participate: No, it's free
  • Measured Outcome: Learner Knowledge, Learner/Team Competence
  • Provider Ship: Jointly Provided
  • Registration: Open to all
«
»
Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x

Contact us

If you want to join leaders who will shape what Americans think about sleep.

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.

Sign up for the expert list

for media inquiries

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.